<DOC>
	<DOCNO>NCT00059722</DOCNO>
	<brief_summary>The purpose study compare efficacy ZD6474 ZD1839 patient NSCLC Failure Prior Platinum-based Chemotherapy .</brief_summary>
	<brief_title>This Study Compare Efficacy ZD6474 ZD1839 Subjects With NSCLC .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Failure either firstline and/or secondline chemotherapy either platinumbased ( prior regimen must fail subject toxicity progression tumor Prior histologic cytologic confirmation locally advanced metastatic ( IIIB/IV ) NSCLC Subjects receive secondline subsequent chemotherapy Any evidence clinically active interstitial lung disease ( patient chronic , stable , radiographic change asymptomatic , need exclude )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>locally advanced metastatic</keyword>
	<keyword>second-line</keyword>
</DOC>